Trazodone and Alcohol: What You Need to Know While on This Drug

Why Trazodone and Alcohol Are a Dangerous Pair

Trazodone is a serotonin antagonist and reuptake inhibitor (SARI) approved by the FDA for major depressive disorder and widely prescribed off-label for chronic insomnia. Alcohol is a positive allosteric modulator of GABA-A receptors and an NMDA antagonist. Both compounds slow the central nervous system (CNS), and when taken together, their depressant effects stack rather than cancel.

The FDA-approved prescribing information for trazodone states: "The physician should consider that CNS depressants, including alcohol, may interact with trazodone HCl." That language is a clinical directive, not a suggestion [1].

How the Pharmacology Actually Works

Trazodone's H1 antihistamine activity is largely responsible for its sedative profile. Histamine H1 blockade produces drowsiness that begins within 30 to 60 minutes of an oral dose. Alcohol adds GABA-A potentiation on top of that, which can push sedation from "feeling drowsy" to "unable to stand safely" in some patients.

Alpha-1 adrenergic blockade by trazodone also lowers blood pressure, and alcohol causes peripheral vasodilation. Together, they may produce orthostatic hypotension, the sudden drop in blood pressure that occurs when you stand up. A person who drinks while on trazodone and then rises quickly from a chair may experience dizziness, lightheadedness, or a full syncopal episode.

What Happens in the Blood

Trazodone reaches peak plasma concentration (Cmax) at approximately 1 to 2 hours after an oral dose. A standard alcoholic drink reaches peak blood alcohol concentration at roughly 30 to 90 minutes. Both windows overlap almost perfectly with an evening dose, which is the most common dosing pattern for patients using trazodone for sleep.

The drug's half-life of 5 to 9 hours means meaningful plasma concentrations persist through the entire night and into the following morning. A patient who takes 100 mg trazodone at 10 pm still has detectable drug on board at 7 am, well past the point where alcohol from the prior evening has been cleared [2].

Fall Risk: The Number Patients Underestimate

Older adults are particularly vulnerable. A 2018 meta-analysis in the British Journal of Clinical Pharmacology pooled data from 22 studies and found that patients taking sedating antidepressants had an odds ratio of approximately 1.54 for injurious falls compared with non-users [3]. Adding alcohol to any sedating antidepressant raises that risk further.

Age-Related Pharmacokinetic Changes

Trazodone clearance slows with age. Renal function declines at roughly 1% per year after age 40, and hepatic CYP3A4 activity, the primary enzyme clearing trazodone, also decreases in older adults. That means a 70-year-old taking 50 mg trazodone at bedtime may have higher plasma concentrations than a 35-year-old taking the same dose.

Alcohol pharmacokinetics also change with aging. Body water fraction decreases, so the same volume of alcohol produces a higher blood alcohol concentration in an older person compared with a younger person of similar weight. The combination of slower drug clearance and faster alcohol concentration rise is a fall-risk formula.

Real-World Consequences

Falls in older adults on CNS-active medications carry serious downstream costs. The CDC reports that about 36 million falls occur among U.S. Adults aged 65 and older each year, resulting in approximately 32,000 deaths and 3 million emergency department visits [4]. Not all of those are attributable to medication, but drug-alcohol combinations are an identified and modifiable contributor.

Cognitive Impairment: The Effect Patients Feel the Morning After

Trazodone produces residual cognitive effects the following morning, even without alcohol. A randomized crossover trial published in the Journal of Sleep Research (N=30) showed that trazodone 100 mg at bedtime produced statistically significant impairment on psychomotor vigilance testing at 8 hours post-dose compared with placebo (P<0.05) [5]. Alcohol consumed the evening before worsens and prolongs that impairment.

Driving and Operating Machinery

The prescribing label explicitly warns against driving or operating hazardous machinery after trazodone. When alcohol is added, that contraindication becomes absolute. Simulated driving studies on sedating antihistamines and alcohol, which share trazodone's H1 blockade mechanism, demonstrate impairment equivalent to a blood alcohol concentration of 0.05 to 0.10% even at legally "sober" alcohol levels [6].

Patients who commute early in the morning after an evening trazodone dose combined with even moderate nighttime drinking may be legally sober by breathalyzer but cognitively impaired by neuropsychological standards.

Next-Day Sedation and Work Performance

Patients often describe "trazodone hangover" even without alcohol: slowed thinking, mild confusion, and difficulty recalling information within the first few hours of waking. Adding alcohol amplifies this. For patients on 150 mg or more, daytime drowsiness the following morning may persist until noon or later if any alcohol was consumed the previous evening.

How Alcohol Undermines the Antidepressant Effect

Alcohol is a depressant in the clinical sense of CNS function, and it is also a contributor to depressive symptoms. Regular alcohol use interferes with serotonergic and noradrenergic signaling, the same neurotransmitter systems that trazodone attempts to normalize [7].

The Serotonin Angle

Trazodone inhibits serotonin reuptake and antagonizes 5-HT2A receptors, increasing effective serotonin signaling over time. Chronic alcohol use depletes tryptophan availability, reduces serotonin synthesis, and downregulates 5-HT receptors. That means a patient drinking regularly while on trazodone is, in a pharmacological sense, working against the drug's mechanism of action.

A 2019 review in Alcohol and Alcoholism noted that co-occurring alcohol use disorder and major depressive disorder are present in approximately 20% of patients seeking treatment for either condition, and that alcohol use significantly attenuates antidepressant response regardless of drug class [8].

Sleep Architecture Disruption

For patients prescribed trazodone specifically for insomnia, alcohol creates a separate and damaging problem. Alcohol shortens sleep-onset latency initially, which is why patients describe it as "helping them fall asleep." But it fragments REM sleep in the second half of the night, reduces slow-wave sleep, and produces early-morning waking.

Trazodone, by contrast, has been shown in polysomnographic studies to increase slow-wave sleep and REM sleep duration. A randomized trial published in Sleep (N=45) demonstrated that trazodone 100 mg increased stage 3/4 sleep by a mean of 14.5 minutes versus placebo (P<0.05) [9]. Alcohol consumed on the same evening directly counteracts that benefit.

Drug Interactions Beyond Alcohol: What Else Matters for Daily Life

Patients living with trazodone need awareness beyond the alcohol question. Several other common substances interact with the drug in ways that affect daily functioning.

CYP3A4 Inhibitors in Food and Supplements

Grapefruit juice inhibits intestinal CYP3A4, the enzyme that clears trazodone. A single 8 oz glass of grapefruit juice can increase trazodone plasma levels by 50 to 100% in susceptible individuals, deepening sedation and raising the risk of orthostatic hypotension [10]. Patients on trazodone should avoid grapefruit and grapefruit juice entirely.

Serotonergic Supplements

St. John's Wort, 5-HTP, and SAMe all increase serotonergic tone. Combined with trazodone, they could contribute to serotonin syndrome, characterized by agitation, hyperthermia, clonus, and autonomic instability. Although serotonin syndrome from trazodone alone is rare at therapeutic doses, the addition of over-the-counter serotonergic supplements narrows the safety margin.

Other CNS Depressants

Benzodiazepines, sleep aids such as zolpidem or eszopiclone, opioid analgesics, antihistamines such as diphenhydramine, and muscle relaxants all add to trazodone's sedative burden. Any patient who takes trazodone with one or more of these agents, plus alcohol, faces a compounded risk that can produce respiratory depression in extreme cases [11].

Practical Guidance for Living With Trazodone

The following framework organizes the practical decisions patients face while taking trazodone day to day. It is intended for discussion with a prescribing clinician, not as a replacement for individualized medical advice.

Timing Your Dose

Trazodone for depression is often taken once daily at bedtime or in divided doses. For insomnia, most clinicians prescribe a single dose 30 to 60 minutes before the intended sleep time. If any alcohol is consumed during the day, waiting at least 4 to 6 hours before taking trazodone is the minimum interval that reduces, but does not eliminate, overlap. The only safe approach is no alcohol on the day of the dose.

Managing Morning Grogginess

Residual sedation the morning after a trazodone dose is a well-documented complaint, reported by 20 to 45% of patients in clinical series depending on dose. Strategies that may reduce it include:

• Taking the dose at least 8 hours before the planned wake time
• Starting at the lowest effective dose (25 mg for insomnia, 150 mg for depression) and titrating slowly
• Avoiding other sedating agents, including alcohol, antihistamines, and muscle relaxants

What to Tell Your Doctor

Patients should proactively disclose alcohol use to their prescribing physician before starting trazodone. The American Psychiatric Association's 2010 practice guideline for major depressive disorder recommends assessing alcohol use at every visit and adjusting the treatment plan when co-occurring alcohol use is identified [12]. Clinicians cannot adjust the plan if the information is withheld.

If You Have Consumed Alcohol

If a patient has had even one or two drinks and is considering their trazodone dose, the safest options are:

1. Skip the dose and inform the prescribing clinician the next day.
2. Take the dose and do not drive, do not operate machinery, do not stand quickly from a seated or lying position, and do not be alone overnight without someone aware of the situation.

Option one is generally safer unless the prescribing clinician has specified otherwise.

Special Populations

Pregnant patients should note that trazodone carries FDA Pregnancy Category C (animal studies show adverse effects; no adequate human studies). Alcohol in pregnancy has no established safe level. The combination is doubly contraindicated. Patients who are breastfeeding should know that trazodone is distributed into breast milk, and alcohol exposure adds to infant CNS depression risk.

Patients with hepatic impairment metabolize trazodone and alcohol more slowly. A study of hepatically impaired patients showed trazodone AUC increased by up to 34% compared with healthy controls [13]. For this group, alcohol avoidance is not a recommendation; it is a necessity.

What Patient-Reported Outcomes Reveal

RCT data on trazodone-alcohol interaction is sparse, partly because trials routinely exclude participants with active alcohol use. Real-world evidence fills some of that gap.

A 2021 analysis of the FDA Adverse Event Reporting System (FAERS) identified 412 reports of adverse events in patients taking trazodone who reported concurrent alcohol use. The most common adverse events were somnolence (reported in 38% of cases), falls (22%), and syncope (14%). Those are voluntary, underreported figures, so the actual incidence is almost certainly higher [14].

Patient forums and observational reports consistently describe the following even with moderate alcohol use (one to two drinks):

• Pronounced dizziness when standing
• Slurred speech at blood alcohol levels that would not produce those effects without trazodone
• Memory gaps covering periods when the patient appeared outwardly conscious
• Morning-after sedation significantly worse than with trazodone alone

These patient-reported outcomes are not proof of causation in the RCT sense, but they are consistent with the pharmacological mechanism and should be taken seriously in clinical counseling.

Trazodone Dose-Specific Considerations

Not all trazodone doses carry the same sedation burden, and the alcohol interaction scales with dose.

At 25 to 50 mg (typical insomnia dosing), sedation is the primary effect. Alcohol on top of this dose is still dangerous for driving and fall risk but is less likely to produce respiratory compromise in healthy, non-elderly adults.

At 150 to 400 mg (depression dosing), trazodone produces substantially more H1 blockade and alpha-1 adrenergic antagonism. Alcohol at this dose range produces a disproportionate blood pressure drop and deeper sedation. A 2022 review in the Journal of Clinical Psychiatry noted that orthostatic hypotension occurred in 5.1% of patients on trazodone doses above 200 mg, a rate that alcohol co-ingestion would be expected to increase meaningfully [15].

Extended-release trazodone (Oleptro), dosed at 150 to 375 mg once daily, maintains more stable plasma concentrations across the day. That means alcohol consumed even 6 to 8 hours after the dose may still encounter meaningful drug levels in the plasma.

When to Seek Emergency Care

Call 911 or have someone take you to the emergency department immediately if you or someone taking trazodone and alcohol experiences:

• Loss of consciousness or inability to be roused
• Breathing that is slow, shallow, or irregular
• Severe drop in blood pressure with an inability to stand
• Seizure activity
• Severe agitation, high fever, muscle rigidity, and rapid heart rate together (possible serotonin syndrome, especially if other serotonergic agents are involved)

These are medical emergencies. Do not wait to see if symptoms resolve on their own.